Improving treatment strategies for opioid addiction and misuse
Official title: CTN HEAL ENHANCEMENT. CLINICAL COORDINATING CENTER FOR NIDA'S CLINICAL TRIALS NETWORK. TO2. POP: 8/15/24 - 11/1/2026
Funded at The Emmes Company, LLC · NIH-11220982 · Data updated 2026-11-12
This study is looking for better ways to help people dealing with opioid addiction, and it will involve patients trying out new treatment methods to find what works best for lasting recovery.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | The Emmes Company, LLC NIH-funded |
| Lab location | 1 site (Rockville, United States) |
| Project start | August 15, 2024 |
| Project end | November 1, 2026 |
| Funding year | 2024 |
| Award (this year) | $2,988,430 |
| NIH project number | 75N95024D00037-0-759502400002-1 |
| Project ID | NIH-11220982 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals experiencing opioid addiction or misuse who are seeking new treatment options.
✕Less likely to help
Patients who are not struggling with opioid addiction or misuse may not benefit from this research.
What this research studies
This research focuses on developing effective solutions to address the opioid crisis in the United States. It is part of the NIH's HEAL initiative, which aims to enhance treatment options for individuals struggling with opioid misuse and addiction. The project will involve collaboration across various clinical trials to identify and implement strategies that can provide lasting relief and support for those affected by opioid dependence. Patients may be involved in trials that test new treatment methods and approaches.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for opioid addiction, improving recovery outcomes for patients.
How similar studies have gone: Previous research under the HEAL initiative has shown promise in developing effective strategies for opioid addiction treatment, indicating a strong potential for success in this area.
Where this research is happening
-
The Emmes Company, LLC
Rockville, United States Active
Researchers
- Principal investigator: Jelstrom, Eve — The Emmes Company, LLC
- Study coordinator: Jelstrom, Eve
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.